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Angeles, Los Angeles, CA, United States, 3 Department of Tumor Immunology, School of Dentistry and Medicine, University of 
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United States
The combined/synergistic effect of genetic mutation of KRAS in the pancreas 
and obesity, a life-style factor on suppression of natural killer (NK) cells at the pre- 
neoplastic stage of pancreatic cancer has not been investigated and is the subject of 
this report. Obese mice with KRAS (KC) mutation in the pancreas fed with high-fat cal-
orie diet (HFCD) exhibit severe deficiencies in the NK cell expansion and function at the 
pre-neoplastic stage of pancreatic cancer. Decreased NK cell-mediated cytotoxicity is 
observed in the peripheral blood, spleen, pancreas, and peri-pancreatic adipose tissue 
in obese KC mice, whereas in bone marrow an increased NK cell-mediated cytotoxicity 
is observed when compared to lean WT mice fed with control diet (CD). Obese KC mice 
on HFCD demonstrated the least ability to expand NK cells or induce NK cell-mediated 
cytotoxicity when compared to the other groups of mice. Indeed, the following profile 
WT/CD > WT/HFCD > KC/CD > KC/HFCD was seen for the ability to expand NK cells 
or mediate cytotoxicity among four groups of mice in spleen, peripheral blood, pancreas, 
and peri-pancreatic adipose tissue. Sorted NK cells from the splenocytes of four groups 
of mice also exhibited the same profiles for the cytotoxicity as the unsorted splenocytes, 
and a decreased IFN-γ secretion could be seen in cultures of NK cells from KC mice fed 
with either CD or HFCD. Cultures of NK cells with autologous monocytes from obese 
KC mice fed with HFCD exhibited decreased cytotoxicity and IFN-γ secretion, whereas 
cultures of allogeneic NK cells from WT mice fed with CD with osteoclasts of obese mice 
fed with HFCD demonstrated decreased cytotoxicity but augmented IFN-γ secretion. 
Increased IL-6 along with decreased IFN-γ and cell-mediated cytotoxicity by the NK 
cells, within NK-adipose tissue of KC/HFCD mice, may provide safe microenvironment 
for the expansion of pancreatic tumors.
Keywords: natural killer cells, Kras, iFn-γ, hFcD, control diet, pre-neoplastic lesions
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highlighTs
•	 KRAS	 mutation	 of	 pancreas	 and/or	 feeding	 with	 HFCD	 is	




•	 NK  cell	 defects	 are	 seen	 during	 activation	 of	 NK  cells	 by	
autologous	monocytes	 in	mice	with	KRAS	mutation	 and/or	
fed	with	HFCD




•	 Decreased	 killing	 but	 augmented	 IFN-γ	 is	 observed	 when	
allogeneic	 NK  cells	 obtained	 from	 WT	 mice	 interact	 with	
osteoclasts	from	KC	mice	on	HFCD.
sUMMarY
We	have	previously	 shown	 that	NK  cells	 select	 and	differenti-
ate	 cancer	 stem	cells	 (CSCs)/undifferentiated	 tumors	by	direct	
killing	of	CSCs	and	secretion	of	 IFN-γ	which	 lead	 to	differen-
tiation	of	CSCs,	respectively.	These	are	two	important	functions	
of	 NK  cells	 which	 prevent	 establishment	 and	 progression	 of	
cancer.	Here,	we	show	defects	 in	expansion,	killing,	and	secre-
tion	of	IFN-γ	by	NK cells	 in	mice	which	have	KRAS	mutation	



















mutations	are	associated	with	 reduced	patient	 survival	 in	both	
malignant	exocrine	and	PDAC	(9,	10).
Obesity	 can	 lead	 to	 intra-pancreatic	 fatty	 infiltration	 and	 is	
associated	 with	 an	 increased	 risk	 of	 pancreatic	 cancer	 and	 its	
precursor	lesions	(11–13).	Because	of	high	prevalence	of	obesity	
in	the	United	States,	greater	attention	must	be	given	to	its	preven-
tion	 and	management	 (14).	 Impaired	 immune	 function	 in	 the	
presence	of	excess	adipose	tissue	has	been	demonstrated	both	in	
humans	and	genetically	obese	rodents	(15–17).	It	was	previously	
shown	 that	 high-fat	 diet	 significantly	 elevated	 the	 pancreatic	
neoplasm	incidence	(18,	19).	However,	it’s	effect	on	natural	killer	
(NK)	 cell	 expansion	 and	 function	 which	 constitutes	 first	 line	
of	defense	 against	 establishment	 and	progression	of	pancreatic	
tumors	has	not	been	clearly	established.
Natural	Killer	cells	are	large	granular	lymphocytes	function-






























tumors	 (47–49).	 However,	 the	 underlying	mechanisms	 of	 the	
contribution	 of	 fatty	 infiltrate	 in	 tumor	 induction	 have	 not	
been	elucidated.	High	numbers	of	NK cells	contribute	to	better	
prognosis	in	pancreatic	adenocarcinoma	patients	(50).
We	have	 recently	 shown	 that	 a	decrease	 in	 cytotoxicity	 and	
lower	 IFN-γ	 secretion	 by	 osteoclast-expanded	 NK  cells	 both	
from	 pancreatic	 cancer	 patients	 and	 tumor-bearing	 human-












by	 lower	 expression	 of	 activating	 surface	 receptors,	 decreased	
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and	metastasis	 of	 pancreatic	 tumors.	 Potential	 contribution	 of	
IL-6	 induced	by	peri-pancreatic	adipose	 tissue	 in	NK cell	 sup-
pression	is	also	shown	and	discussed.
MaTerials anD MeThODs
conditional Kras(g12D) Mouse Model 
and experimental Diet
To	study	the	effect	of	obesity	and	high-fat	calorie	diet	(HFCD)	
on	 NK	 function	 during	 pancreatic	 cancer	 development,	 the	
conditional	KRAS(G12D)	model	was	used	(58).	After	weaning,	
offspring	 of	 LSL-KRAS(G12D)	 and	 p48-Cre	 (or PDX-1-Cre)	
mice	were	 fed	either	a	HFCD	or	a	 lean	control	diet	 (CD)	 for	
3–4 months.	The	exact	composition	of	the	diets	was	previously	
described	 (59).	 The	 diets	 were	 obtained	 from	 Dyets,	 Inc.,	
Pennsylvania.	 After	 3–4  months,	 mice	 were	 euthanized,	 and	
the	entire	pancreas,	peri-pancreatic	adipose	tissues,	and	other	
organs	 were	 harvested.	 Formalin-fixed,	 paraffin-embedded	
tissues	were	sectioned	(4 µm)	and	stained	with	H&E.	Sections	






Animals.	 Genotyping	 analysis	 was	 performed	 as	 described	
previously	(61).





















with	 10%	 FBS.	 Lipopolysaccharides	 were	 purchased	 from	
Sigma-Aldrich	 (St.	 Louis,	 MO,	 USA).	 Recombinant	 IL-2	 was	
obtained	from	NIH-BRB.	Flow	antibodies	used	in	this	study	were	
purchased	 from	Biolegend	 (San	Diego,	 CA,	USA).	The	mouse	
NK cells	and	monocyte	purification	kits	were	obtained	from	Stem	
Cell	Technologies	(Vancouver,	BC,	Canada).
cell isolations and cultures
Natural	killer	cells	were	isolated	from	splenocytes	using	mouse	
NK  cells	 isolation	 kit	 (Stem-cells	 Technologies,	 Canada).	
Monocytes	were	isolated	from	BM cells	using	monocyte	isolation	




sAJ2	 is	 a	 combination	 of	 eight	 different	 strains	 of	 sonicated	
Gram-positive	 probiotic	 bacteria	 (Streptococcus thermophiles, 
Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium 
infantis, Lactobacillus acidophilus, Lactobacillus plantarum, 








of	 sonication/incubation	 on	 ice	 were	 conducted	 to	 achieve	
complete	sonication.	Finally,	the	sonicated	samples	(sAJ2)	were	
aliquoted	and	stored	in	a	−80°C	freezer	until	use.
generation of Osteoclasts  
and expansion of nK cells
Purified	 mouse	 monocytes	 from	 BM  cells	 were	 cultured	 in	




with	 M-CSF	 and	 RANKL.	 Purified	 NK  cells	 from	 mice	 sple-






The	cells	were	washed	 twice	using	 ice-cold	PBS	with	 1%	BSA.	
Predetermined	optimal	concentrations	of	specific	mouse	mono-




ously	 (64)	 and	 flow	 cytometric	 analysis	 was	 performed	 using	
Beckman	Coulter	Epics	XL	cytometer	(Brea,	CA)	and	results	were	
analyzed	in	FlowJo	vX	software	(Ashland,	OR,	USA).
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elisa
Single	ELISAs	were	performed	and	standard	curve	was	generated	
as	 described	 previously	 (65).	 A	 standard	 curve	 was	 generated	





mercially	 available	multiplex	 assay	 (MILLIPLEX®	MAP	Mouse	






51cr release cytotoxicity assay



















ANOVA	 using	 Turkey’s	 multiple	 comparison	 tests	 was	 used	







Decreased Percentages of DX5+ nK cells 
and nK cell cytotoxic Function in Kc 
Mice Fed With hFcD
We	have	 recently	 demonstrated	 that	KC	mice	 fed	with	HFCD	
exhibited	 increased	body	weight	 as	well	 as	 augmented	 visceral	




lesions	were	 found	 in	WT	mice	 fed	with	 either	CD	or	HFCD.	






To	 evaluate	 the	 effect	 of	 KRAS	 mutation	 and	 HFCD,	 we	





immune	 cells	 from	 different	 tissues	 between	 the	 four	 groups	
of	mice	(Figures	S1A,B	in	Supplementary	Material).	When	the	
percentages	of	DX5+	NK cells	were	determined	in	the	spleen,	
PBMCs,	 pancreas,	 and	 adipose	 tissues	 after	 culture,	 there	










of	NK cells	was	not	due	 to	 the	decline	of	 total	populations	of	
CD45+	 immune	cells	 (Figure	S1A	and	S1B	 in	Supplementary	
Material)	 or	 total	 numbers	 of	 cells	 dissociated	 from	 different	
tissue	 compartments	 (Figure	 S2	 in	 Supplementary	 Material).	
In	 assessments	 of	 spleen,	 pancreas,	 adipose,	 and	 peripheral	
blood,	the	following	pattern	of	cytotoxicity	against	cancer	stem	
cells	 was	 observed	 (WT/CD > WT/HFCD >  KC/CD >  KC/





cytokine	 secretion,	 when	 compared	 to	 the	 spleen,	 pancreas,	
adipose,	 and	 peripheral	 blood	 (Figure	 S3D	 in	 Supplementary	
Material).	Since	IFN-γ	and	IL-6	secretions	were	increased	in	the	
cells	obtained	 from	 the	various	 tissues	of	KC	mice	on	HFCD,	
with	 the	 exception	 of	 BM	 (Figures	 S3B–D	 in	 Supplementary	
Material),	 we	 aimed	 to	 determine	 whether	 other	 cytokines	
were	modulated	similarly	or	differently,	using	Luminex	multi-











and	KC	mice	 fed	with	HFCD	had	 the	highest	 secretion	when	
compared	to	other	groups	of	mice	(Figures	S3B,C	and	Tables	S1	
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cells,	 since	 this	 allowed	us	 to	 summarize	 a	 large	body	of	data	
within	 the	 scatter	plots.	The	great	 agreement	 and	 relationship	
between	cytotoxicity	for	different	effector:target	(E:T)	ratios	and	
LU	30/106	is	shown	in	Figures	S4A,B	in	Supplementary	Material.
Decreased Tumor Killing and iFn-γ 
secretion by Purified nK cells From 











(Figure	S5A	 in	Supplementary	Material)	 and	on	 those	which	
were	 cultured	 (Figure	 S5B	 in	 Supplementary	 Material).	 No	
significant	changes	on	the	surface	expression	of	DX5	could	be	
observed	 in	 purified	NK  cells	 from	 four	 groups	 after	 culture	
(Figure	 S5B	 in	 Supplementary	 Material).	 The	 TLR4	 surface	
expression	was	also	analyzed	on	freshly	isolated	NK cells.	KC	
mice	 expressed	 higher	TLR4	 expression	 as	 compared	 to	WT	
mice,	 and	 KC	mice	 on	HFCD	 expressed	 higher	 TLR4	 when	
compared	 to	KC	mice	on	CD	(Figure 1A).	Similar	 to	spleen,	
pancreas,	and	adipose	cells,	purified	NK cells	from	spleen	acti-
vated	with	 IL-2	 (Figure 1B)	or	with	 IL-2 + LPS	 (Figure 1C)	





IL-2	 (Figure  1D;	 Tables	 S1,	 S3,	 S4	 and	 S5	 in	 Supplementary	
Material)	or	with	IL-2 + LPS	(Figure 1E)	from	KC	mice	fed	with	
HFCD	had	the	least	secretion	of	IFN-γ,	followed	by	KC	mice	fed	
with	CD	 (Figures  1D,E;	 Table	 S5	 in	 Supplementary	Material).	
Activated	NK cells	 from	WT	mice	on	HFCD	had	higher	 levels	
of	secretion	than	WT	mice	on	CD	(Figures 1D,E).	Cytotoxicity	





of	NK cells	with	 combination	of	 IL-2 + LPS	 in	 the	absence	of	
monocytes	lowered	cytotoxicity	substantially	when	compared	to	











(Figure  1G),	 similar	 profiles	 of	 IFN-γ	 secretion,	 as	 seen	with	
IL-2-activated	NK cells	in	the	absence	of	monocytes	could	also	
be	observed	 (Figures 1G,I).	Similar	 to	PBMCs,	 IL-6	 secretion	
by	the	NK cells	was	higher	in	mice	on	HFCD	(please	see	below).	
T cells	isolated	and	cultured	in	the	same	manner	as	NK cells,	with	
and	without	monocytes,	were	 not	 able	 to	 kill	NK  cell-specific	
targets	(Figure	S6A	in	Supplementary	Material).	In	contrast	to	
NK  cells,	 no	 decrease	 in	 the	 induction	 of	 IFN-γ	 secretion	 by	
T cells	activated	with	IL-2 + LPS	and	cultured	with	monocytes	
could	 be	 observed	 in	 KC	mice	 on	HFCD	when	 compared	 to	




Osteoclasts (Ocs) From Kc Mice  
on hFcD are Defective in increasing 
numbers and Killing of allogeneic  








when	 compared	 to	 either	WT	mice	 or	KC	mice	 fed	with	CD	
(Figure 2A).	As	 shown	 in	Figure 2B,	OCs	 from	KC	mice	 fed	
with	HFCD	when	cultured	with	allogeneic	NK cells	from	WT	
mice	 on	 CD	 in	 the	 presence	 of	 LPS	 had	 the	 least	 ability	 to	
expand	NK cells	when	compared	to	OCs	from	WT	mice	on	CD	
or	HFCD	or	KC	mice	fed	with	CD	(Figure 2B).	Similar	results	
were	 seen	 when	OCs	 were	 cultured	 with	 allogeneic	 NK  cells	
from	WT	mice	on	CD	in	the	presence	of	sAJ2	(data	not	shown).	
NK  cells	 from	WT	 mice	 when	 cultured	 with	 the	 OCs	 from	
WT	 or	 KC	mice	 on	HFCD	 in	 the	 presence	 of	 LPS	mediated	








levels	 of	 IFN-γ	 when	 compared	 to	 those	 obtained	 from	WT	
mice	 on	 the	 CD	 (Figures  2D–G).	 Accordingly,	 much	 higher	
levels	of	inflammatory	cytokines	and	chemokines	were	secreted	
from	 NK  cells	 expanded	 by	 OCs	 from	 KC	 mice	 on	 HFCD,	
FigUre 1 | Natural killer (NK) cells from KC mice fed with control diet (CD) or high-fat calorie diet when cultured with autologous monocytes demonstrated less 
cytotoxicity and decreased IFN-γ secretion when compared to WT mice fed with CD. WT and KC mice were fed with a CD or high-fat calorie diet as described in 
Section “Materials and Methods.” Splenocytes were harvested after animals were sacrificed and single cell suspension was prepared as described in Section 
“Materials and Methods” and used to purify NK cells. TLR4 surface expression on the purified NK cells from four groups of mice was analyzed using antibody 
staining followed by flow cytometric analysis. One of three representative experiments is shown in the (a). Purified NK cells from splenocytes were activated with 
IL-2 (10,000 U/ml) (n = 4) (B,D) or with IL-2 (10,000 U/ml) in the presence of LPS (100 ng/ml) (n = 4) (c,e) before they were used as effector cells in a standard 4-h 
51Chromium release assay. The lytic units (LUs) 30/106 cells were determined using the inverse number of NK cells required to lyse 30% of the ST63 cells ×100 
(n = 4) (B,c), and the supernatants were harvested after culture to determine the levels of IFN-γ secretion (n = 4) (D,e). IL-2-treated and IL-2 and LPS-treated 
NK cells as described in (c,e) were cultured with or without autologous monocytes at NK:monocytes; 1:0.5 ratio before they were used as effector cells in a 
standard 4-h 51Chromium release assay. The lytic units (LUs) 30/106 cells were determined using the inverse number of NK cells required to lyse 30% of the ST63 
cells ×100. One of five representative experiments is shown in (F). The supernatants were harvested to determine the levels of IFN-γ secretion. One of five 
representative experiments is shown in the (g). IL-2-treated NK cells (h) and IL-2 and LPS-treated NK cells (i) were cultured with autologous monocytes at 
NK:monocytes; 1:0.5 ratio before the supernatants were harvested to determine the levels of IFN-γ secretion (n = 3).
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followed	 by	 those	 expanded	 by	 osteoclasts	 from	KC	mice	 on	
CD	and	WT	mice	on	HFCD	(Figures 2D–G;	Tables	S6	and	S7	
in	Supplementary	Material).
secretion of il-6 by the Peri-Pancreatic 
adipose Tissue From Obese Mice is 
synergistically increased in the Presence 
of Decreased iFn-γ From nK cells
Peri-pancreatic	adipose	tissue	was	dissociated,	and	the	cells	were	
cultured	in	the	presence	or	absence	of	IL-2-activated	autologous	
NK cells	 and	 the	 levels	of	 IL-6	 and	 IFN-γ	were	determined	 in	
WT	mice	fed	with	CD	and	KC	mice	fed	with	HFCD	(Figure 3).	
NK cells	secreted	IL-6	moderately,	whereas	significant	secretion	




mice	 fed	 with	 CD	 (Figure  3A).	The	 inverse	 was	 seen	 for	 the	
secretion	of	IFN-γ	in	the	cultures	of	NK cells	with	adipose	tissue,	
in	which	increased	amounts	of	IFN-γ	secretion	and	augmented	
NK  cell-mediated	 cytotoxicity,	 could	 be	 seen	 by	WT	mice	 fed	
with	CD	and	less	with	KC	mice	fed	with	HFCD	(Figures 3B,C).	
Thus,	 increased	IL-6	secretion	was	observed	 in	the	presence	of	
decreased	 NK  cell-mediated	 cytotoxicity	 as	 well	 as	 decreased	
secretion	of	IFN-γ	in	KC	mice	fed	with	HFCD.
FigUre 2 | Allogeneic natural killer (NK) cells from WT mice fed with control diet (CD) expanded less and mediated less cytotoxicity, but demonstrated augmented 
IFN-γ secretion when cultured with osteoclasts from KC mice fed with high-fat calorie diet. WT and KC mice were fed with a CD or high-fat calorie diet as described 
in Section “Materials and Methods.” Bone marrow was harvested after animals were sacrificed and single cell suspension was prepared as described in Section 
“Materials and Methods.” Monocytes were purified from the BM cells and were used to generate OCs as described in Section “Materials and Methods.” Flow 
cytometric analysis was used to determine expression of RAE1-delta and MHC-class I on day 21 mature OCs (a). NK cells purified from splenocytes of WT mice 
fed with CD were activated with IL-2 (10,000 U/ml) and LPS (100 ng/ml), and cultured in the presence/absence of OCs from different mouse groups at NK:OCs; 
1:0.5 ratio, and the number of expanded NK cells were determined on the days shown in the (B). NK cells expanded by the OCs as described in (B) were used as 
effector cells in a standard 4-h 51Chromium release assay. The LUs 30/106 cells were determined as described in Figure 1B (c). NK cells were purified from WT 
splenocytes and cultured with OCs as described in (B,D,e) or treated with IL-2 in the presence of sonicated AJ2 (sAJ2) and cultured with OCs at the ratio of 
(0.5:1:2; OCs:NK:sAJ2) (F,g) and the supernatants were harvested on the days shown in the figures and secretion of IFN-γ were determined. One of three 
representative experiments is shown in Figure 2.
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compared to Kc Tumors, Panins express 
lower cD44 and are not susceptible to 
nK cells Mediated cytotoxicity
Single	 cell	 suspensions	 of	 PanINs	 and	 KC	 pancreatic	 tumors	
were	 obtained	 from	 KC	 mice	 and	 used	 to	 determine	 CD44	
surface	 receptor	 expression	 and	 susceptibility	 to	 NK  cells	
mediated	cytotoxicity.	As	shown	in	Figure	S7	in	Supplementary	
Material,	 PanINs	 expressed	 relatively	 lower	 levels	 of	 CD44	
expression	 (Figure	 S7A	 in	 Supplementary	Material),	 and	 they	
were	significantly	more	resistant	to	NK cells	mediated	cytotoxic-







suppressed	 in	 many	 cancer	 patients	 (51),	 however,	 it	 is	 still	
unknown	whether	the	establishment	of	cancer	is	responsible	for	
the	 suppression	of	NK  cells	 or	 lack	 of	NK  cell	 function	 at	 the	
pre-malignant,	 dysplastic	 stage	 is	 one	 of	 the	 driving	 forces	 for	
the	establishment	and	growth	of	cancer	or	both.	Studies	reported	
in	 this	paper	are	novel,	 since	 for	 the	first	 time	we	demonstrate	
that	NK cell	loss	occurs	at	the	pre-malignant	stage	of	cancer,	and	
FigUre 3 | Secretion of IL-6 by the peri-pancreatic adipose tissue from obese mice is synergistically increased in the presence of natural killer (NK) cells. Purified 
NK cells from splenocytes and adipocytes from the peri-pancreatic fat were obtained from WT mice on CD or KC mice on HFCD as described in Section “Materials 
and Methods.” NK cells treated with IL-2 (10,000 U/ml) in the presence and absence of autologous adipose cells at (NK:adipose cells; 1:1) were cultured and 
supernatants were harvested after 7 days and the secretion of IL-6 (a) and IFN-γ (B) were determined. One of the three representative experiments is shown in  
the figures. Cytotoxicity of NK cells cultured as described in (a,B) were assessed against ST63 tumor cells using the standard 4-h 51Chromium release assay.  
The LUs 30/106 cells were determined as described in Figure 1B (c). One of three representative experiments is shown in the figure.
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is	 associated	with	KRAS	mutation	 in	 the	pancreas	 and	obesity	
which	are	likely	contributing	factors	in	the	progression	of	cancer	
from	dysplastic	 stage	 to	overt	cancer.	We	demonstrate	 that	 the	
loss	of	NK cell	expansion	and	function	at	the	pre-neoplastic	stage	
correlates	with	increased	levels	and	intensity	of	dysplastic	lesions,	











of	 these	 tumors.	 We	 have	 also	 shown	 that	 NK-differentiated	
tumors	proliferate	or	expand	less,	and	exhibit	higher	expression	




of	 CD44	 and	 are	 susceptible	 to	NK  cell-mediated	 cytotoxicity	
exhibiting	more	 of	 poorly	 differentiated	 phenotype	 (Figure	 S7	
in	 Supplementary	Material).	Therefore,	 based	on	 these	profiles	
one	may	expect	 lower	NK cell	 inactivation	 in	mice	 at	 the	pre-
neoplastic	 stage	 than	when	overt	cancer	 is	 established.	 Indeed,	
severe	inhibition	of	NK	cell	functions	is	seen	in	pancreatic	cancer	
patients,	whereas	 at	 the	 pre-neoplastic	 stages	 of	 tumorigenesis	
the	severity	of	NK	cell	suppression	may	be	 lower,	with	gradual	
increases	in	severity	when	the	cells	accumulate	more	mutations	
and	 become	 overt	 cancer	 (51).	 In	 addition,	 loss	 of	 NK  cell-

















from	the	 tissues	of	 these	mice.	However,	 there	was	an	 inverse	
correlation	 between	 secretion	 of	 IFN-γ	 and	 those	 of	NK  cell-
mediated	 cytotoxicity	 when	 total	 cells	 from	 the	 dissociated	
tissues	 were	 cultured	 (Figure	 S3	 in	 Supplementary	Material).	
Although	such	profiles	could	be	due	to	split-anergized	NK cells,	




Indeed,	 due	 to	 the	 inactivation	 of	NK  cell	 function	 in	 cancer	
patients,	we	observe	faster	expansion	of	T cells	which	results	in	
FigUre 4 | Schematic representation of hypothetical model of interaction between NK cells, adipose tissue, and pancreatic tumors. Adipose tissue within and 
around tumor microenvironment can contribute to the increased proliferation of pancreatic tumors through the increase in induction of IL-6 in the presence of 
decreased IFN-γ secretion by the NK cells. NK cells and monocytes are recruited to the peri-pancreatic and pancreatic adipose tissue from the circulation, where 
they are conditioned by the adipose tissue to lose secretion of IFN-γ, while increasing synergistically secretion of IL-6 by the peri-pancreatic and pancreatic 
adipose-derived cells. Since pancreatic tumors have a predilection to grow in the adipose tissue, these tissues are likely to convert tumor suppressive NK cells, to 
tumor-promoting cells, by decreasing NK-mediated cytotoxicity and IFN-γ secretion and allowing an increased secretion of IL-6 within the tumor microenvironment. 
Increased IL-6 secretion is instrumental in aiding in tumor growth and expansion.
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in	 secretion	of	 IFN-γ	 by	 autologous	NK cells	 could	be	due	 to	
the	extent	of	defect	in	NK cells,	since	osteoclasts	from	KC	mice	
on	HFCD	although	severely	restricted	expansion	of	allogeneic	
NK  cells,	 and	 NK  cells	 exhibited	 decreased	 cytotoxicity,	 they	
showed	 increased	 secretion	 of	 IFN-γ.	 In	 contrast,	 monocytes	
from	 KC	 mice	 on	 HFCD	 decreased	 expansion,	 cytotoxicity,	
as	 well	 as	 IFN-γ	 secretion	 by	 autologous	 NK  cells	 indicating	
perhaps	 more	 severe	 inactivation	 of	 autologous	 NK  cells.	
Thus,	 depending	on	 the	 inflammatory	microenvironment	 and	
the	extent	of	defect	 in	NK cells	 and	 in	 those	 supporting	 their	
activation,	different	degrees	of	functional	loss	of	NK cells	may	be	
seen.	Indeed,	we	have	previously	reported	four	stages	of	NK cell	
maturation	 and	 activation	 depending	 on	 the	 competency	 of	






are	 likely	 in	 stage	 2,	 since	 they	 have	 no/lower	 cytotoxicity	 in	
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on	OCs	in	combination	with	decreased	expansion	and	function	
of	NK cells	may	be	a	better	indicator	of	PanIN	induction.
In	 contrast	 to	 other	 tissues,	 bone	 marrow	 from	 KC	 mice	
demonstrated	higher	NK	cytotoxicity	 in	 the	presence	of	 lower	
IFN-γ	secretion	(Figure	S3	in	Supplementary	Material).	At	the	
moment,	it	is	unclear	why	NK cells	from	bone	marrow	behave	
differently	 when	 compared	 to	 the	 other	 tissues	 examined,	
however,	 since	 NK  cells	 develop	 and	mature	 within	 BM	 it	 is	
possible	 that	 the	 microenvironment	 provides	 the	 primary	
activating	signals	which	drive	their	initial	activation,	and	when	
such	activated	NK cells	exit	to	the	periphery,	additional	signals	












Synergistic	 increase	 in	 the	 IL-6	 secretion	 in	 KC/HFCD	 as	
compared	 to	WT/CD	 by	 the	 peri-pancreatic	 adipose-derived	
cells	with	NK cells	in	the	presence	of	decreased	IFN-γ	secretion	
(54%	decrease	 in	KC/HFCD	 as	 compared	 to	WT/CD),	 could	
be	one	mechanism	by	which	the	adipose	tissue	can	contribute	
to	 the	 increased	 proliferation	 of	 pancreatic	 tumors.	 Indeed,	
IL-6	is	one	of	the	major	drivers	of	PDAC	proliferation	(73–77)	
and	 suppression	 of	 NK	 function	 (78).	 Moreover,	 addition	 of	
IL-6	 to	 tumor/NK	 cultures	 inhibited	 NK-mediated	 IFN-γ	
secretion	in	our	previous	studies	(42,	69,	71,	79,	80).	Therefore,	
since	tumors	have	a	predilection	to	grow	in	the	adipose	tissue,	
these	 tissues	are	 likely	 to	convert	 tumor	suppressive	NK cells,	
to	 tumor-promoting	cells.	Blocking	 IL-6	may	not	only	 inhibit	
tumor	growth	but	also	it	may	rescue	NK cells	from	suppression	
mediated	 by	 the	 adipose	 tissue	 or	 tumor	 tissues	 and	 offer	 an	
attractive	and	effective	therapeutic	strategy	to	target	pancreatic	
tumors	(Figures 3	and	4).
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